Literature DB >> 7016103

Histiocytic lymphoma presenting with extrahepatic biliary obstruction: a report of three cases.

I F Young, I C Roberts-Thomson, J R Sullivan.   

Abstract

Three patients with histiocytic lymphoma presented with jaundice due to extrahepatic biliary obstruction. Two had widespread disease, but one had a primary lymphoma of the head of the pancreas simulating pancreatic cancer. Biliary bypass surgery was avoided in two patients, both of whom showed resolution of jaundice following treatment with cytotoxic chemotherapeutic drugs.

Entities:  

Mesh:

Year:  1981        PMID: 7016103     DOI: 10.1111/j.1445-2197.1981.tb05934.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  7 in total

1.  Diagnostic approach to patients with cholestatic jaundice.

Authors:  N Assy; G Jacob; G Spira; Y Edoute
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

Review 2.  Lymphoma predominantly involving the pancreas.

Authors:  M S Cappell; F Yao; K C Cho; C A Axiotis
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

3.  Biliary tract obstruction secondary to malignant lymphoma: experience at a referral center.

Authors:  Bülent Odemiş; Erkan Parlak; Omer Başar; Osman Yüksel; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

4.  Primary pancreatic lymphoma forming a giant mass in a short period: A case report.

Authors:  Naoyasu Yoshida; Masaru Nakamura; Hiroyasu Yamada
Journal:  J Med Ultrason (2001)       Date:  2003-06       Impact factor: 1.314

5.  Pancreatic lymphoma, diagnosis and management.

Authors:  P C Brown; M J Hart; T T White
Journal:  Int J Pancreatol       Date:  1987-04

Review 6.  Malignant lymphoma of the pancreas.

Authors:  T Tanaka; Y Matsugu; K Koide; Y Miura; Y Ichiba; K Dohi; H Ito
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

7.  Renal lymphoma: an unusual cause of extrahepatic biliary obstruction.

Authors:  Z Abbas; D A Johnston; F E Murray
Journal:  Postgrad Med J       Date:  1996-10       Impact factor: 2.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.